Resistant forms of acne

R. M. Abdrakhmanov, Z. R. Sadykova

Research output: Contribution to journalArticle

Abstract

The global problem of increasing cases of antibiotic resistance in patients with acne is mainly determined by the regional prescription practices and patient compliance with doctor's directions and genomic variability of Propionibacterium acnes. The research was aimed at analyzing the causal profile and risk factors for development of resistant forms of acne. Crosssectional study of the causal profile was conducted and risk factors for development of resistant forms of acne were studied on the basis of dermatological clinics of the city in Kazan, Republic of Tatarstan, among 983 patients with acne of both genders aged 18 to 41 years. Bacteria were isolated using the bacteriological method, sensitivity to antibiotics was determined by the Kirby-Bauer disk diffusion test, the risk factors were analyzed by calculating the odds ratio in the procedure of logistic regression. Most often, the pathogens of the disease were Propionibacterium acnes (70.60%). The share of resistant strains was 91.66% with erythromycin, 91.25% with clindamycin, 96.64% with azithromycin, and 91.35% with laevomycetin (p<0.001). The highest sensitivity was observed for levofloxacin (96.74%) (p<0.001). Risk factors were smoking (OR=3.15; 95% CI: 0.57-2.61), disruptions of the hormonal-endocrine profile (OR=4.71; 95% CI: 2.43-5.12), being female (OR=1.41; 95% CI: 1.04-2.99), duration of disease over 5 years (OR=3.16; 95% CI: 1.67-4.03), and impractical antimicrobial therapy (OR=5.11; 95% CI: 3.17-6.15). Reducing the frequency of resistant forms requires rational prescription of antibacterial preparations, prescription delivery of antibiotics, and reduction of individual risk factors.

Original languageEnglish
Pages (from-to)1342-1345
Number of pages4
JournalJournal of Pharmaceutical Sciences and Research
Volume10
Issue number6
Publication statusPublished - Jun 1 2018
Externally publishedYes

Fingerprint

Acne Vulgaris
Prescriptions
Propionibacterium acnes
Tatarstan
Anti-Bacterial Agents
Levofloxacin
Azithromycin
Clindamycin
Erythromycin
Patient Compliance
Microbial Drug Resistance
Logistic Models
Smoking
Odds Ratio
Bacteria
Research

Keywords

  • Acne
  • Propionibacterium acnes
  • Resistant strains

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Abdrakhmanov, R. M., & Sadykova, Z. R. (2018). Resistant forms of acne. Journal of Pharmaceutical Sciences and Research, 10(6), 1342-1345.

Resistant forms of acne. / Abdrakhmanov, R. M.; Sadykova, Z. R.

In: Journal of Pharmaceutical Sciences and Research, Vol. 10, No. 6, 01.06.2018, p. 1342-1345.

Research output: Contribution to journalArticle

Abdrakhmanov, RM & Sadykova, ZR 2018, 'Resistant forms of acne', Journal of Pharmaceutical Sciences and Research, vol. 10, no. 6, pp. 1342-1345.
Abdrakhmanov RM, Sadykova ZR. Resistant forms of acne. Journal of Pharmaceutical Sciences and Research. 2018 Jun 1;10(6):1342-1345.
Abdrakhmanov, R. M. ; Sadykova, Z. R. / Resistant forms of acne. In: Journal of Pharmaceutical Sciences and Research. 2018 ; Vol. 10, No. 6. pp. 1342-1345.
@article{6c62f974950540bca0201337cdbb53c2,
title = "Resistant forms of acne",
abstract = "The global problem of increasing cases of antibiotic resistance in patients with acne is mainly determined by the regional prescription practices and patient compliance with doctor's directions and genomic variability of Propionibacterium acnes. The research was aimed at analyzing the causal profile and risk factors for development of resistant forms of acne. Crosssectional study of the causal profile was conducted and risk factors for development of resistant forms of acne were studied on the basis of dermatological clinics of the city in Kazan, Republic of Tatarstan, among 983 patients with acne of both genders aged 18 to 41 years. Bacteria were isolated using the bacteriological method, sensitivity to antibiotics was determined by the Kirby-Bauer disk diffusion test, the risk factors were analyzed by calculating the odds ratio in the procedure of logistic regression. Most often, the pathogens of the disease were Propionibacterium acnes (70.60{\%}). The share of resistant strains was 91.66{\%} with erythromycin, 91.25{\%} with clindamycin, 96.64{\%} with azithromycin, and 91.35{\%} with laevomycetin (p<0.001). The highest sensitivity was observed for levofloxacin (96.74{\%}) (p<0.001). Risk factors were smoking (OR=3.15; 95{\%} CI: 0.57-2.61), disruptions of the hormonal-endocrine profile (OR=4.71; 95{\%} CI: 2.43-5.12), being female (OR=1.41; 95{\%} CI: 1.04-2.99), duration of disease over 5 years (OR=3.16; 95{\%} CI: 1.67-4.03), and impractical antimicrobial therapy (OR=5.11; 95{\%} CI: 3.17-6.15). Reducing the frequency of resistant forms requires rational prescription of antibacterial preparations, prescription delivery of antibiotics, and reduction of individual risk factors.",
keywords = "Acne, Propionibacterium acnes, Resistant strains",
author = "Abdrakhmanov, {R. M.} and Sadykova, {Z. R.}",
year = "2018",
month = "6",
day = "1",
language = "English",
volume = "10",
pages = "1342--1345",
journal = "Journal of Pharmaceutical Sciences and Research",
issn = "0975-1459",
publisher = "PharmaInfo Publications",
number = "6",

}

TY - JOUR

T1 - Resistant forms of acne

AU - Abdrakhmanov, R. M.

AU - Sadykova, Z. R.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The global problem of increasing cases of antibiotic resistance in patients with acne is mainly determined by the regional prescription practices and patient compliance with doctor's directions and genomic variability of Propionibacterium acnes. The research was aimed at analyzing the causal profile and risk factors for development of resistant forms of acne. Crosssectional study of the causal profile was conducted and risk factors for development of resistant forms of acne were studied on the basis of dermatological clinics of the city in Kazan, Republic of Tatarstan, among 983 patients with acne of both genders aged 18 to 41 years. Bacteria were isolated using the bacteriological method, sensitivity to antibiotics was determined by the Kirby-Bauer disk diffusion test, the risk factors were analyzed by calculating the odds ratio in the procedure of logistic regression. Most often, the pathogens of the disease were Propionibacterium acnes (70.60%). The share of resistant strains was 91.66% with erythromycin, 91.25% with clindamycin, 96.64% with azithromycin, and 91.35% with laevomycetin (p<0.001). The highest sensitivity was observed for levofloxacin (96.74%) (p<0.001). Risk factors were smoking (OR=3.15; 95% CI: 0.57-2.61), disruptions of the hormonal-endocrine profile (OR=4.71; 95% CI: 2.43-5.12), being female (OR=1.41; 95% CI: 1.04-2.99), duration of disease over 5 years (OR=3.16; 95% CI: 1.67-4.03), and impractical antimicrobial therapy (OR=5.11; 95% CI: 3.17-6.15). Reducing the frequency of resistant forms requires rational prescription of antibacterial preparations, prescription delivery of antibiotics, and reduction of individual risk factors.

AB - The global problem of increasing cases of antibiotic resistance in patients with acne is mainly determined by the regional prescription practices and patient compliance with doctor's directions and genomic variability of Propionibacterium acnes. The research was aimed at analyzing the causal profile and risk factors for development of resistant forms of acne. Crosssectional study of the causal profile was conducted and risk factors for development of resistant forms of acne were studied on the basis of dermatological clinics of the city in Kazan, Republic of Tatarstan, among 983 patients with acne of both genders aged 18 to 41 years. Bacteria were isolated using the bacteriological method, sensitivity to antibiotics was determined by the Kirby-Bauer disk diffusion test, the risk factors were analyzed by calculating the odds ratio in the procedure of logistic regression. Most often, the pathogens of the disease were Propionibacterium acnes (70.60%). The share of resistant strains was 91.66% with erythromycin, 91.25% with clindamycin, 96.64% with azithromycin, and 91.35% with laevomycetin (p<0.001). The highest sensitivity was observed for levofloxacin (96.74%) (p<0.001). Risk factors were smoking (OR=3.15; 95% CI: 0.57-2.61), disruptions of the hormonal-endocrine profile (OR=4.71; 95% CI: 2.43-5.12), being female (OR=1.41; 95% CI: 1.04-2.99), duration of disease over 5 years (OR=3.16; 95% CI: 1.67-4.03), and impractical antimicrobial therapy (OR=5.11; 95% CI: 3.17-6.15). Reducing the frequency of resistant forms requires rational prescription of antibacterial preparations, prescription delivery of antibiotics, and reduction of individual risk factors.

KW - Acne

KW - Propionibacterium acnes

KW - Resistant strains

UR - http://www.scopus.com/inward/record.url?scp=85049490756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049490756&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 1342

EP - 1345

JO - Journal of Pharmaceutical Sciences and Research

JF - Journal of Pharmaceutical Sciences and Research

SN - 0975-1459

IS - 6

ER -